Envestnet Asset Management’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.16M | Sell |
47,736
-22,593
| -32% | -$550K | ﹤0.01% | 3191 |
|
|
2025
Q1 | $1.46M | Sell |
70,329
-2,380
| -3% | -$49.4K | ﹤0.01% | 2941 |
|
|
2024
Q4 | $1.71M | Sell |
72,709
-11,384
| -14% | -$268K | ﹤0.01% | 2798 |
|
|
2024
Q3 | $2.15M | Sell |
84,093
-8,054
| -9% | -$206K | ﹤0.01% | 2606 |
|
|
2024
Q2 | $2.16M | Sell |
92,147
-1,056
| -1% | -$24.8K | ﹤0.01% | 2553 |
|
|
2024
Q1 | $2.68M | Sell |
93,203
-22,285
| -19% | -$641K | ﹤0.01% | 2384 |
|
|
2023
Q4 | $3.79M | Buy |
115,488
+13,489
| +13% | +$443K | ﹤0.01% | 2074 |
|
|
2023
Q3 | $2.84M | Sell |
101,999
-2,528
| -2% | -$70.4K | ﹤0.01% | 2160 |
|
|
2023
Q2 | $3.56M | Sell |
104,527
-314
| -0.3% | -$10.7K | ﹤0.01% | 1913 |
|
|
2023
Q1 | $3.15M | Buy |
104,841
+3,331
| +3% | +$100K | ﹤0.01% | 1911 |
|
|
2022
Q4 | $2.87M | Sell |
101,510
-20,498
| -17% | -$579K | ﹤0.01% | 1936 |
|
|
2022
Q3 | $4.01M | Sell |
122,008
-3,369
| -3% | -$111K | ﹤0.01% | 1645 |
|
|
2022
Q2 | $3.95M | Sell |
125,377
-5,528
| -4% | -$174K | ﹤0.01% | 1656 |
|
|
2022
Q1 | $6.01M | Buy |
130,905
+5,736
| +5% | +$263K | ﹤0.01% | 1488 |
|
|
2021
Q4 | $7.67M | Sell |
125,169
-15,973
| -11% | -$978K | ﹤0.01% | 1339 |
|
|
2021
Q3 | $10.5M | Sell |
141,142
-15,201
| -10% | -$1.14M | 0.01% | 1116 |
|
|
2021
Q2 | $14.5M | Buy |
156,343
+19,248
| +14% | +$1.78M | 0.01% | 935 |
|
|
2021
Q1 | $12.2M | Buy |
137,095
+45,322
| +49% | +$4.02M | 0.01% | 940 |
|
|
2020
Q4 | $8.56M | Buy |
91,773
+58,063
| +172% | +$5.42M | 0.01% | 982 |
|
|
2020
Q3 | $2.15M | Buy |
33,710
+26,271
| +353% | +$1.67M | ﹤0.01% | 1582 |
|
|
2020
Q2 | $388K | Buy |
+7,439
| New | +$388K | ﹤0.01% | 2556 |
|
|
2019
Q4 | – | Sell |
-8,110
| Closed | -$239K | – | 3076 |
|
|
2019
Q3 | $239K | Buy |
8,110
+1,984
| +32% | +$58.5K | ﹤0.01% | 2776 |
|
|
2019
Q2 | $211K | Buy |
+6,126
| New | +$211K | ﹤0.01% | 2858 |
|